afdx 384 has been researched along with bibn 99 in 1 studies
| Studies (afdx 384) | Trials (afdx 384) | Recent Studies (post-2010) (afdx 384) | Studies (bibn 99) | Trials (bibn 99) | Recent Studies (post-2010) (bibn 99) |
|---|---|---|---|---|---|
| 78 | 0 | 6 | 11 | 0 | 0 |
| 5 | 0 | 0 | 11 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubert, I; Doods, H; Meaney, MJ; Parent, A; Quirion, R; Richard, J; Rowe, W; White, N; Wilson, A | 1 |
1 other study(ies) available for afdx 384 and bibn 99
| Article | Year |
|---|---|
Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired.
Topics: Acetylcholine; Aging; Animals; Cognition; Dibenzazepines; Male; Maze Learning; Memory Disorders; Muscarinic Antagonists; Parasympatholytics; Pirenzepine; Pyridines; Rats; Rats, Inbred Strains; Scopolamine | 1995 |